Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
JN.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDTEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.617.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.109 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.8 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.617.1 (Kappa)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.620EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used